Astaxanthin sources: Suitability for human health and nutrition
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Astaxanthin (AX) has been consumed as a nutritional supplement for approximately twenty years. The primary source has been a natural plant-based supplement from the single-cell alga Haematococcus pluvialis (NAT-AX). Recently, Astaxanthin from other sources has entered the marketplace. The primary alternative source in the human nutritional supplement market has been a synthetic form of Astaxanthin produced from petrochemicals (SYN-AX). Additionally, a very small amount of Astaxanthin from a genetically-manipulated yeast Xanthophyllomyces dendrorhous (former nomenclature Phaffia rhodozyma, still commonly referred to as “Phaffia”) (PH-AX) is also available in some supplement products. The three forms have substantial chemical differences. In addition to the chemical differences between sources of AX, in-vitro research has demonstrated profound differences in antioxidant strength and animal research has revealed fundamental differences in health benefits. In all cases, NAT-AX has proven more biologically active than the other sources. This review is designed to assist readers in understanding which form(s) of AX are suitable for consumers desiring preventive or therapeutic health benefits. Results: In head-to-head antioxidant experiments, NAT-AX demonstrated 14X to 90X greater antioxidant activity than SYN-AX. In numerous animal trials in diverse species, NAT-AX in esterified form has demonstrated superior efficacy in increasing lifespan; treating skin cancer; preventing the formation of gastric ulcers; improving resistance to stress; decreasing reactive oxygen species (ROS); increasing retinol conversion in the liver; augmenting enzyme levels; increasing growth rates; and improving exercise endurance.From a safety perspective, NAT-AX has been the subject of human clinical trials demonstrating safety and a wide variety of health benefits. In addition, no documented adverse events have surfaced during its twenty years of distribution as a food supplement for humans. SYN-AX and PH-AX have not been proven safe for direct human consumption and have not demonstrated any health benefits in clinical trials. Due to these facts, SYN-AX and PH-AX have not been allowed for human consumption by government regulators in many countries while NAT-AX is widely accepted in most countries around the world. Conclusion: Based on our review of the literature below, we recommend NAT-AX as the sole form of AX for human consumption until SYN-AX and PH-AX have been proven safe and efficacious through human clinical research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haematococcus astaxanthin: applications for human health and nutrition
Guerin, M., Huntley, M. E., & Olaizola, M. (2003) · Trends in Biotechnology · doi:10.1016/s0167-7799(03)00078-7 · Cited by 1,495
Beutner, S., Bloedorn, B., Frixel, S., Hernández Blanco, I., Hoffmann, T., Martin, H., Mayer, B., Noack, P., Ruck, C., Schmidt, M., et al. (2001) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.849 · Cited by 253 · cited 1×
“Additionally, while carotenes such as BC and lycopene can become pro-oxidants under certain conditions and hasten the proliferation of ROS, AX has never shown the capacity to create a pro-oxidant effect [5].”
BackgroundUlcer preventive and antioxidative properties of astaxanthin from Haematococcus pluvialis
Kamath, B. S., Srikanta, B. M., Dharmesh, S. M., Sarada, R., & Ravishankar, G. A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.042 · Cited by 162
Cited by
Microalgal Cell Biofactory—Therapeutic, Nutraceutical and Functional Food Applications
Kiran, B. R., & Venkata Mohan, S. (2021) · Plants · doi:10.3390/plants10050836 · Cited by 124
“…diabetes, neurodegenerative and ocular diseases, lung injury, repressed alveolar wall swelling and myeloperoxidase activity Cai et al., 2019 [65]; Capelli et al., 2019 [32]; Chang et al., 2010 [66]; Galasso et al., 2019 [30]; Park et al., 2010 [67]; Talukdar et al., 2020 [33]; Wu et al., 2014…”
BackgroundOslan, S. N. H., Tan, J. S., Oslan, S. N., Matanjun, P., Mokhtar, R. A. M., Shapawi, R., & Huda, N. (2021) · Molecules · doi:10.3390/molecules26216470 · Cited by 121
Ayub, A., Rahayu, F., Khamidah, A., Antarlina, S. S., Iswari, K., Supriyadi, K., Mufidah, E., Singh, A., Chopra, C., & Wani, A. K. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-06916-3 · Cited by 29
“…o e r y t h r i n L l u e - g r ee n , g r ee n , o r e v e n r e dd i s h - b r o w n , P o w d e r o r l i q u i d e x t r a c t I m p r o v e s l i g h t u t i l i z a t i o n e ffi c i e n c y [ 42 , 43 ] P r o t o t h e c a z o p fi i ( f o r m e r l y P r o t o t h e c a m o r i f o r m i s )”
Metadata
- Authors
- Capelli, B., Talbott, S., & Ding, L.
- Venue
- Functional Foods in Health and Disease
- Publisher
- Functional Food Center
- Published
- 2019-07-01
- Volume
- 9
- Issue
- 6
- Pages
- 430
- ISSN
- 2160-3855 (ISSN-L)
- 2378-7007
- OpenAlex
- W2955847149
- Cited by
- 67
- References
- 3
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.